TOP TIERMARKET NEWSWIRE
SEC Form 4 history

KURA ONCOLOGY INC (KURA) insider trades

KURA ONCOLOGY INC (KURA) insider trading activity (SEC Form 4). Over the trailing 90 days, KURA insiders filed 2 purchases totalling $2.4M and 8 sales totalling $1.7M — net BUYING of $643K. Most recent filing: Sep 29, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
2
$2.4M
Sells (90d)
8
$1.7M
Net (90d)
+$643K
net buying
Most recent
Sep 29, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Sep 29, 2026Powl Brian T.Chief Commercial OfficerS Sale—$10.63$345Kfiling
Sep 29, 2026Doyle Thomas JamesSVP, Finance, AccountingS Sale—$10.50$48Kfiling
Sep 29, 2026Leoni MollieChief Medical OfficerS Sale—$10.67$440Kfiling
Sep 29, 2026Ford KathleenCOOS Sale—$10.59$112Kfiling
Sep 29, 2026Bair Teresa BrophyGCS Sale—$10.50$89Kfiling
Sep 25, 2026Burrows FrancisChief Scientific OfficerS SaleOE—$10.83$225Kfiling
Aug 24, 2026Wilson Troy EdwardPres, CEOP Purchase—$12.39$1.2Mfiling
Aug 24, 2026Powl Brian T.Chief Commercial OfficerS Sale—$11.89$52Kfiling
Aug 21, 2026Bair Teresa BrophyGCS Sale—$12.63$398Kfiling
Aug 17, 2026Wilson Troy EdwardPres, CEOP Purchase—$11.12$1.1Mfiling
Jun 22, 2026Leoni MollieChief Medical OfficerS Sale—$9.82$834Kfiling
May 22, 2026Powl Brian T.Chief Commercial OfficerS Sale—$11.00$110Kfiling